期刊文献+

二甲双胍联合门冬胰岛素对2型糖尿病患者糖代谢功能的影响 被引量:1

Effects of metformin combined with insulin aspart on glucose metabolism in patients with type 2 diabetes mellitus
原文传递
导出
摘要 目的观察二甲双胍联合门冬胰岛素对2型糖尿病患者糖代谢功能的影响。方法选取2型糖尿病患者120例,采用随机数表字法分为对照组及观察组,每组60例。对照组使用门冬胰岛素治疗,观察组在对照组基础上加用二甲双胍治疗,比较两组糖代谢功能改善情况及用药安全性。结果治疗后,观察组糖代谢功能优于对照组,差异有统计学意义(P<0.05);观察组不良反应发生率略低于对照组,差异未见统计学意义(P>0.05)。结论 2型糖尿病患者使用二甲双胍联合门冬胰岛素治疗,可有效改善患者糖代谢功能,且不增加不良反应,用药安全性高。 Objective To observe the effect of metformin combined with insulin aspart on glucose metabolism in patients with type 2 diabetes mellitus. Methods One hundred and twenty patients with type 2 diabetes were selected,they were randomly divided into control group and observation group,with 60 cases in each group. The control group was treated with insulin aspart,while the observation group was treated with metformin on the basis of the control group. The improvement of glucose metabolism function and drug safety of the two groups were compared. Results After treatment,glucose metabolism function in the observation group was significantly better than that in the control group,the difference was significant( P〈0. 05); the adverse reaction rate of the observation group was slightly lower than that of the control group,but the difference was not significant( P〉0. 05). Conclusions Metformin combined with insulin aspart in the treatment of patients with type 2 diabetes mellitus can effectively improve the glucose metabolism,and without increase the adverse reactions. It has high safety and remarkable curative effect.
作者 黄黎峰
出处 《临床医学》 CAS 2017年第9期91-92,共2页 Clinical Medicine
关键词 二甲双胍 门冬胰岛素 2型糖尿病 糖代谢功能 Metformin Insulin aspart Type 2 diabetes mellitus Glucose metabolism function
  • 相关文献

参考文献7

二级参考文献38

  • 1Ceriello A,Esposito K,Piconi L. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients[J].{H}DIABETES,2008,(05):1349-1354.
  • 2Bragd J,Adamson U,Baeklund LB. Can glycaemie variability,as calculated from blood glucose self-monitoring,prediet the development of complications in type 1 diabetes over a decade[J].Diabetes Metabolism,2008,(06):612-616.
  • 3Mormier L,Colette C,Boegner C. Continuous glucose monitoring in patients with type 2 diabetes:Why When Whom[J].Diabetes Metabolism,2007,(04):247-252.
  • 4Helmersson J,Arnlov J,Vessby B. Serum selenium predicts levels of F2-isoprostanes and prostaglandin F2alpha in a 27 year follow-up study of Swedish men[J].{H}Free Radical Research,2005,(07):763-770.
  • 5高妍,郭晓蕙,周智广等. 每日三次双时相门冬胰岛素(BIASP50-50-30)联合二甲双胍和每日两次双时相门冬胰岛素3 0 联合二甲双胍对2 型糖尿病患者的疗效和安全性比较[A]. 中华医学会、中华医学会内分泌学分会.中华医学会第十一次全国内分泌学学术会议论文汇编[C] . 中华医学会、中华医学会内分泌学分会,2012: 1.
  • 6柏松,时艺珊,王晓蕾,石峰,鞠巍,赵冬.门冬胰岛素30联合二甲双胍治疗2型糖尿病临床观察[J].中国医药导报,2009,6(33):57-58. 被引量:18
  • 7孙伟,朱江,徐勉.门冬胰岛素30治疗2型糖尿病疗效观察[J].蚌埠医学院学报,2010,35(1):35-36. 被引量:8
  • 8蒋铁桥,程春瑞,杨刚毅,李伶,陈文雯,李生兵.门冬胰岛素每日3次方案联合二甲双胍治疗2型糖尿病[J].中国新药与临床杂志,2010,29(7):499-502. 被引量:4
  • 9张儒雅,陆菊明.DPP-4抑制剂在2型糖尿病治疗中的应用[J].中华内分泌代谢杂志,2011,27(1):101-104. 被引量:75
  • 10王立新.门冬胰岛素30治疗2型糖尿病临床观察[J].中国医药导报,2011,8(4):148-149. 被引量:8

共引文献88

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部